Literature DB >> 7888854

New or old antidepressants? Benefits of new drugs are exaggerated.

D Owens1.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7888854      PMCID: PMC2541811          DOI: 10.1136/bmj.309.6964.1281

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  The use of animals in research.

Authors:  P Lachmann
Journal:  BMJ       Date:  1992-07-04

2.  Selective serotonin reuptake inhibitors.

Authors:  J G Edwards
Journal:  BMJ       Date:  1992-06-27

3.  Effective and acceptable treatment for depression.

Authors:  S Milne; A Alcorn; A J Bell
Journal:  BMJ       Date:  1993-04-24

4.  Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.

Authors:  F Song; N Freemantle; T A Sheldon; A House; P Watson; A Long; J Mason
Journal:  BMJ       Date:  1993-03-13

5.  Suicide and fatal antidepressant poisoning.

Authors:  J A Henry; C A Antao
Journal:  Eur J Med       Date:  1992-10
  5 in total
  7 in total

Review 1.  Selective serotonin reuptake inhibitors. Assessment for formulary inclusion.

Authors:  B H Guze
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

Review 2.  Paroxetine. A pharmacoeconomic evaluation of its use in depression.

Authors:  M I Wilde; R Whittington
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

3.  Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.

Authors:  I M Anderson; B M Tomenson
Journal:  BMJ       Date:  1995-06-03

4.  Antidepressant drug choice for first users in two regions in The Netherlands.

Authors:  A C Egberts; M Veenstra; L T de Jong-van den Berg
Journal:  Pharm World Sci       Date:  1999-06

Review 5.  Mirtazapine. A pharmacoeconomic review of its use in depression.

Authors:  K J Holm; B Jarvis; R H Foster
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 6.  The need for an iterative process for assessing economic outcomes associated with SSRIs.

Authors:  T L Skaer; D A Sclar; L M Robison; R S Galin
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

7.  A comparative survey of antidepressant drug prescribing habits of general practitioners and psychiatrists.

Authors:  M Lapeyre-Mestre; K Desboeuf; I Aptel; J J Chale; J L Montastruc
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.